1.10 Reduced exocrine secretions
First line drugs | Second line drugs | Specialist drugs | Secondary care drugs |
Traffic light status (TLS) explained:
- Green: Routine prescribing within licensed indication
- Amber 1: specialist recommendation followed by GP initiation and continuation
- Amber 2: specialist or GP initiation in line with local guideline after 1st line failure followed by GP continuation
- Amber 3: specialist initiation and stabilisation followed by GP continuation
- Amber SCG: specialist initiation and stabilisation followed by GP continuation in line with an agreed shared care guideline
- Red: Hospital or specialist prescribing only
Pancreatic enzymes
Pancreatin
Creon®
- Capsules 10,000
Creon® Micro
- 20G Granule pack
Higher-strength preparations
Creon®
- Capsules 25,000 (High strength)
- Capsules 40,000 (High strength)
Note:
- The CSM has advised of data associating the high-strength pancreatin preparations with the development of large bowel strictures in children with cystic fibrosis aged between 2 and 13 years.
- They have recommended that the total dose of pancreatic enzyme supplements used in patients with cystic fibrosis should not usually exceed 10,000 units of lipase per kg body-weight daily.
Return to Chapter: 1. Gastro-Intestinal System
Last updated by: Dupe Fagbenro on 05-02-2019 15:58